Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement
NCT00681356
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
214
Enrollment
INDUSTRY
Sponsor class
Conditions
Total Knee Arthroplasty (Replacement)
Interventions
DRUG:
4975, 15 and 5 mg
DRUG:
Placebo Comparator
DRUG:
4975 - 5 mg
Sponsor
Anesiva, Inc.